Bloomberg Opinion Expanding IPO Access Could Benefit Ordinary Investors Michael Saylor Tokenization Could Enable Investors to Shop for Yield Disrupting Traditional Banking Trump Urges Supreme Court to Halt TikTok Ban What It Means for Investors US Consumer Prices Rise 38 Annually in April Topping Expectations Home Depot HD Price Target Cut by 20 in Morgan Stanley Analyst Note Japan and Philippines Deepen Strategic Partnership Amid Regional Security Shifts BRC Group Holdings Inc 550 Senior Notes Due 2026 RILYK Q1 2024 Earnings Negative EPS Highlights Operational Strain as Bond Price Edges Higher VLGEA Q1 2025 Earnings Profitability Holds Steady Amidst Challenging Retail Environment PEW Q1 2026 Earnings NarrowerThanExpected Loss Surprises Analysts TNDM Q1 2026 Earnings NarrowerthanExpected Loss as EPS Surprises Positively Workday Q1 2026 Earnings EPS Beat Propels Stock Higher Amid Solid Execution PVL Q1 2023 Earnings Trust Reports EPS of 013 Amid Energy Royalty Trends Greenwich LifeSciences GLSI Surges 7 as Biotech Momentum Builds Globalstar Inc GSAT Holds Near Support Amid Modest Pullback Traders Eye Key Levels NPACU Units Trade Flat as Support Holds Steady Near 10 Level TORM plc TRMD Declines 284 as Selling Pressure Tests Key Support Zone Energizer Holdings ENR Gains 2 as Stock Tests Key Resistance Frankfurt Airports New Sky Line Train Faces Technical Disruption Shortly After Launch Recursion Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Pipeline Progress Merchants Bancorp Preferred Stock MBINL Holds Steady Near Resistance After Modest Uptick KW Q1 2026 Earnings Significant EPS Beat Driven by Operational Strength Legato Merger Corp III LEGT Q1 2026 Earnings SPAC Reports Positive EPS Amid Quiet Quarter BHC Q1 2026 Earnings EPS Surprises to the Upside Amidst Operational Uncertainty RHP Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Group Demand ARDX Q1 2026 Earnings EPS Misses Estimates Amid Quiet Revenue Disclosure STZ Q1 2026 Earnings EPS Beats Estimates by 948 as Stock Edges Lower ATYR Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline Without Revenue